Tag: Agilus Diagnostics
Duo acts on Fortis Healthcare’s INR1.7bn buy of Agilus stake
Saraf & Partners and TT&A advised Fortis Healthcare on its INR1.77 billion (USD207 million) acquisition of a 31.52% stake in Agilus Diagnostics
Saraf & Partners and TT&A advised Fortis Healthcare on its INR1.77 billion (USD207 million) acquisition of a 31.52% stake in Agilus Diagnostics
Follow us on LinkedIn